NAGE Operating Cash Flow (Statement)
Niagen Bioscience Inc · Operating Cash Flow (Statement)
NAGE Operating Cash Flow (Statement)
Latest reported$5.95Mperiod ending
NAGE TTM Cash from Operations (-$38.48K → $5.95M)
TTM operating cash flow (statement)
High-resolution chart · PNG
NAGE operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 5,949,000 | |
| 4,427,000 | |
| 13,504,000 | |
| 21,408,000 | |
| 21,211,000 | |
| 19,697,000 | |
| 12,109,000 | |
| 4,175,000 | |
| 1,076,000 | |
| 4,620,000 | |
| 7,117,000 | |
| 6,140,000 | |
| 2,004,000 | |
| -5,108,000 | |
| -15,098,000 | |
| -19,714,000 | |
| -21,893,000 | |
| -25,956,000 | |
| -24,163,000 | |
| -19,197,000 | |
| -17,123,000 | |
| -10,784,000 | |
| -10,600,000 | |
| -11,232,000 | |
| -15,147,000 | |
| -22,612,000 | |
| -20,439,000 | |
| -24,965,000 | |
| -22,440,000 | |
| -19,967,000 | |
| -20,908,000 | |
| -19,538,977 | |
| -14,778,977 | |
| -13,741,977 | |
| -9,803,977 | |
| -5,845,814 | |
| -5,511,209 | |
| -91,524 | |
| -2,936,596 | |
| -3,981,358 | |
| -4,601,349 | |
| -4,416,152 | |
| -2,111,138 | |
| -1,503,300 | |
| -1,129,428 | |
| -1,766,679 | |
| -2,580,406 | |
| -4,067,502 | |
| -3,768,105 | |
| -4,604,994 | |
| -3,906,011 | |
| -2,923,019 | |
| -3,854,212 | |
| -6,169,278 | |
| -10,119,713 | |
| -10,970,909 | |
| -11,390,251 | |
| -9,002,356 | |
| -4,098,829 | |
| -3,344,600 | |
| -2,250,881 | |
| -2,578,317 | |
| -2,661,550 | |
| -1,681,120 | |
| -1,409,305 | |
| 19,196 | |
| -396,172 | |
| -758,116 | |
| -1,528,383 | |
| -1,322,019 | |
| -1,074,354 | |
| -850,333 | |
| -25,933 | |
| -38,483 |